Literature DB >> 23374599

Levels of indoxyl sulfate are associated with severity of coronary atherosclerosis.

Chia-Chang Hsu1, Yung-Chuan Lu, Cheng-An Chiu, Teng-Hung Yu, Wei-Chin Hung, Chao-Ping Wang, Li-Fen Lu, Fu-Mei Chung, Yau-Jiunn Lee, I-Ting Tsai.   

Abstract

PURPOSE: Indoxyl sulfate (IS) is linked to endothelial damage, NF-κB activation and induced development of atherosclerosis. The purpose of this study was to investigate the relationship between serum IS levels and the severity of coronary artery stenosis. In addition, the relationship among IS and various cardiovascular risk factors was also explored.
METHODS: Serum IS concentrations were measured using ultra performance liquid chromatography in 191 consecutive patients presenting with stable angina. The associations between serum IS levels and angiographic indexes of the number of diseased vessels, modified Gensini scores and calcium scores were determined.
RESULTS: Patients with significant coronary artery stenosis were found to have higher serum IS levels than patients with normal coronary arteries. Using multivariate analysis, serum IS levels were found to be independently associated with the presence and severity of coronary artery disease (CAD). Furthermore, statistically significant correlation was observed between the serum IS levels and age, Agatston calcium score, volume calcium score, modified Gensini score, coronary lesions, coronary disease and Framingham-10 year risk score.
CONCLUSION: This study indicates that serum IS levels are significantly higher in the presence of CAD and correlate with the severity of the disease and coronary atherosclerosis scores, which suggest that increased serum IS may be involved in the pathogenesis of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374599     DOI: 10.25011/cim.v36i1.19404

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  16 in total

1.  Association of indoxyl sulfate with heart failure among patients on hemodialysis.

Authors:  Xue-Sen Cao; Jun Chen; Jian-Zhou Zou; Yi-Hong Zhong; Jie Teng; Jun Ji; Zhang-Wei Chen; Zhong-Hua Liu; Bo Shen; Yu-Xin Nie; Wen-Lv Lv; Fang-Fang Xiang; Xiao Tan; Xiao-Qiang Ding
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-20       Impact factor: 8.237

2.  Evidence for Indoxyl Sulfate as an Inducer of Oxidative Stress in Patients With Diabetes.

Authors:  Ichiro Wakabayashi; Mikio Marumo
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

3.  Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Yan Chen; Leila R Zelnick; Matthew P Huber; Ke Wang; Nisha Bansal; Andrew N Hoofnagle; Rajan K Paranji; Susan R Heckbert; Noel S Weiss; Alan S Go; Chi-Yuan Hsu; Harold I Feldman; Sushrut S Waikar; Rupal C Mehta; Anand Srivastava; Stephen L Seliger; James P Lash; Anna C Porter; Dominic S Raj; Bryan R Kestenbaum
Journal:  Am J Kidney Dis       Date:  2021-01-07       Impact factor: 11.072

Review 4.  Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

Authors:  Carolla El Chamieh; Sophie Liabeuf; Ziad Massy
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

5.  Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients.

Authors:  Wei-Hua Tang; Chao-Ping Wang; Fu-Mei Chung; Lynn L H Huang; Teng-Hung Yu; Wei-Chin Hung; Li-Fen Lu; Po-Yuan Chen; Ching-Hsing Luo; Kun-Tai Lee; Yau-Jiunn Lee; Wen-Ter Lai
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 6.  Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies.

Authors:  Sheldon C Leong; Tammy L Sirich
Journal:  Toxins (Basel)       Date:  2016-11-30       Impact factor: 4.546

7.  The burden of major adverse cardiac events in patients with coronary artery disease.

Authors:  I-Ting Tsai; Chao-Ping Wang; Yung-Chuan Lu; Wei-Chin Hung; Cheng-Ching Wu; Li-Fen Lu; Fu-Mei Chung; Chia-Chang Hsu; Yau-Jiunn Lee; Teng-Hung Yu
Journal:  BMC Cardiovasc Disord       Date:  2017-01-04       Impact factor: 2.298

Review 8.  Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.

Authors:  Hideki Fujii; Shunsuke Goto; Masafumi Fukagawa
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

Review 9.  Gut microbiota derived metabolites in cardiovascular health and disease.

Authors:  Zeneng Wang; Yongzhong Zhao
Journal:  Protein Cell       Date:  2018-05-03       Impact factor: 14.870

Review 10.  Uremic Toxin Clearance and Cardiovascular Toxicities.

Authors:  Robert D Mair; Tammy L Sirich; Timothy W Meyer
Journal:  Toxins (Basel)       Date:  2018-06-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.